New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
Home > iTeos Therapeutics, Inc.
iTeos Therapeutics, Inc.
Industry: Life Sciences ・ $ITOS on Nasdaq ・ Market Cap: Small
Top Executive Recent Purchases
New Purchase Insider
1Y INSIDER TRADING ACTIVITY
Insider Trade Volume in USD
1Y INSIDER ACTIVITY
TRADES PURCHASE/SALE
Sector Average
1 / 0
2.19 / 7.65
INSIDER BUYERS/SELLERS
Sector Average
1 / 0
1.2 / 2.5
SHARES PURCHASED/SOLD
Transaction Average
5,000 / 0
5,000 / 0
VALUE PURCHASED/SOLD
Transaction Average
$38,650 / $0
$38,650 / $0
PURCHASE RANGE$38,650 - $38,650
SALE RANGEN/A
INSIDER PERFORMANCE OVERVIEW
PURCHASE PERFORMANCE
2 / 8
CEO Purchases
Top Executive Purchases
New Purchase Insider
High Purchase Reporters Count
High Purchase Activity
Regular Purchase Insiders
Abnormal High-Volume Purchases
High Purchases Frequency
SALE PERFORMANCE
0 / 4
CEO Sales
Top Executive Sales
Regular Sale Insiders
High Sales Frequency
1Y PURCHASE DISTRIBUTION
purchase distribution by individual insiders
0%
DIRECTORS
100%
OFFICERS
0%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX
Sector Average
N/A
0.2
VALUE GINI INDEX
Sector Average
N/A
0.206
1Y SALE DISTRIBUTION
sale distribution by individual insiders
No Insider Trades made
0%
DIRECTORS
0%
OFFICERS
0%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX
Sector Average
N/A
0.295
VALUE GINI INDEX
Sector Average
N/A
0.288
iTeos Therapeutics, Inc. 1Y Trade Transactions
Submission Date
Period of Report
InsiderPositionTotal ValueSharesShare PriceOwnership % ChangeShares OwnedPost Day Stock ChangePost Week Stock Change
2024-11-19
2024-11-19
Gall Matthew
Officer
+$38,650
5,000
$7.73
+8.27%
65,429
N/A
N/A
2023-08-25
2023-08-23
Boxer Capital, LLC
Other
-$5,446,000
350,000
$15.56
-16.25%
1,804,058
-4.73%
-4.88%

Get Feature Updates
Subscribe to our newsletter and receive the latest updates. You will get pre-access to new features